Resumen
Introducción. Diferentes pruebas neuropsicológicas permiten explorar las funciones cognitivas del adulto mayor, en un tiempo corto. En Colombia se dispone de pocos estudios sobre puntuaciones y puntos de corte para el MMSE y para el MoCA en relación al diagnóstico de deterioro cognitivo.
Objetivo. Describir la distribución de las puntuaciones del MMSE y el MoCA y los puntos de corte con mejor discriminación, para el diagnóstico de deterioro cognitivo leve y demencia, en una muestra de pacientes de Bogotá.
Material y métodos. Se evaluaron 248 pacientes por un equipo multidisciplinario, que consultaron a la Clínica de Memoria del HIUSJ entre 2009-2012, siguiendo un protocolo establecido. Se identificaron las puntuaciones del MoCA y MMSE, que permitieron obtener el mayor porcentaje de pacientes correctamente clasificados.
Resultados. En el 70% de los pacientes con DCL y en el 69 % de los sujetos normales, se encontraron puntuaciones del MMSE inferiores o iguales a 28. En 91% de pacientes con DCL y 84% de los sujetos normales, se presentaron puntuaciones del MoCA inferiores o iguales a 25. Los pacientes con cualquier tipo de demencia, presentaron puntuaciones del MMSE inferiores o iguales a 27 e inferiores o iguales a 24 en el MoCA.
Conclusión. Según el presente estudio, el tamizaje de funciones cognitivas, utilizando el MoCA, clasifica de manera más acertada que el MMSE, a los sujetos con deterioro cognitivo. Creemos que en atención primaria, estos puntos de corte del MoCA, pueden ser considerados por ahora, cuando se trate especialmente de sujetos con alta escolaridad.
Citas
WIMO A, WINBLAD B, JONSSON L.The worldwide societal costs of dementia: Estimates for 2009. Alzheimers Dement. 2010; 6:98-103.
FERRI CP, PRINCE M, BRAYNE C, BRODATY H, FRATIGLIONI L, GANGULI M, ET AL.Global prevalence of dementia: a Delphi consensus study. Lancet. 2005; 366:2112-7.
PRADILLA G, VESGA BE, LEÓN-SARMIENTO FE. Estudio neuroepidemiológico nacional (EPINEURO) colombiano. Revista Panamericana de Salud Pública. 2003; 14:104-11.
MCKHANN GM, KNOPMAN DS, CHERTKOW H, HYMAN BT, JACK CR JR, KAWAS CH, ET AL. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011; 7:263-9.
FOLSTEIN MF, FOLSTEIN SE, MCHUGH PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of psychiatric research. 1975; 12:189-98.
XU G, MEYER JS, HUANG Y DU F, CHOWD-HURY M, QUACH M. Adapting mini-mental state examination for dementia screening among illiterate or minimally educated elderly Chinese. International journal of geriatric psychiatry. 2003; 18:609-16.
CULLEN B, FAHY S, CUNNINGHAM CJ, COEN RF, BRUCE I, GREENE E, ET AL.Screening for dementia in an Irish community sample using MMSE: a comparison of norm-adjusted versus fixed cut-points. International journal of geriatric psychiatry. 2005; 20:371-6.
DE SILVA HA, GUNATILAKE SB. Mini Mental State Examination in Sinhalese: a sensitive test to screen for dementia in Sri Lanka. International journal of geriatric psychiatry. 2002; 17:134-9.
KULISEVSKY J, PAGONABARRAGA J. Cognitive impairment in Parkinson’s disease: tools for diagnosis and assessment. Movement disorders : official journal of the Movement Disorder Society. 2009; 24:1103- 10.
CRUM RM, ANTHONY JC, BASSET SS, FOLSTEIN MF. Population-based norms for the minimental state examination by age and educational level. JAMA: The Journal of the American Medical Association. 1993; 269:2386-91.
BRAYNA C, CALLOWAY P.The Association of Education and Socioeconomic Status with the Mini Mental State Examination and the Clinical Diagnosis of Dementia in Elderly People. Age and Ageing. 1990; 19:91-6.
TOMBAUGH TN, MCINTYRE NJ. The minimental state examination: a comprehensive review. J Am Geriatr Soc. 1992; 40:922-35.
MITCHELL AJ. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. Journal of psychiatric research. 2009; 43:411-31.
TRENKLE DL, SHANKLE WR, AZEN SP. Detecting cognitive impairment in primary care: performance assessment of three screening instruments. Journal of Alzheimer’s disease: JAD. 2007; 11:323-35.
SHIROKY JS, SCHIPPER HM, BERGMAN H, CHERTKOW H. Can You Have Dementia With an MMSE Score of 30? American journal of Alzheimer’s disease and other dementias. 2007; 22:406-15.
MEMORIA CM, YASSUDA MS, NAKANO EY, FORLENZA OV. Brief screening for mild cognitive impairment: validation of the Brazilian version of the Montreal cognitive assessment. Int J Geriatr Psychiatry. 2012; 28:34-40
FUJIWARA Y, SUZUKI H, YASUNAGA M, SUGIYAMA M, IJUIN M, SAKUMA N, ET AL.Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment. Geriatr Gerontol Iint. 2010; 10:225-32.
NASREDDINE ZS, PHILLIPS NA, BEDIRIAN V, CHARBONNEAU S, WHITEHEAD V, COLLIN I, ET AL. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53:695-9.
GILL DJ, FRESHMAN A, BLENDER JA, RAVINA B. The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson’s disease. Movement disorders: official journal of the Movement Disorder Society. 2008; 23:1043-6.
MCLENNAN SN, MATHIAS JL, BRENNAN LC, STEWART S.Validity of the montreal cognitive assessment (MoCA) as a screening test for mild cognitive impairment (MCI) in a cardiovascular population. Journal of geriatric psychiatry and neurology. 2011; 24:33-8.
ROSSELLI D, ARDILA A, PRADILLA-ARDILA G, MORILLO L, BAUTISTA L, REY O, ET AL. El examen mental abreviado (Mini-Mental State Examination) como prueba de tamizaje para el diagnóstico de demencia: estudio poblacional colombiano. Rev Neurol. 2000; 30:428-32.
AGUIRRE-ACEVEDO DC, GÓMEZ RD, MORENO S, HENAO-ARBOLEDA E, MOTTA M, MUÑOZ C, ET AL. Validez y fiabilidad de la batería neuropsicológica CERAD-Col. Rev Neurol. 2007; 45:655-60.
GÓMEZ F, ZUNZUNEGUI MV, LORD C, ALVARADO B, GARCÍA A, Applicability of the MoCA-S test in populations with little education in Colombia. Int J Geriatr Psychiatry. 2013; 28:813-20.
GROBER E, BUSCHKE H, CRYSTAL H, BANG S, DRESNER R. Screening for dementia by memory testing. Neurology. 1988; 38:900-3.
ZARIT SH, REEVER KE, BACH-PETERSON J.Relatives of the impaired elderly: correlates of feelings of burden. The Gerontologist. 1980; 20:649-55.
FLICKER C, FERRIS SH, REISBERG B. A longitudinal study of cognitive function in elderly persons with subjective memory complaints. J Am Geriatr Soc. 1993; 41:1029-32.
MCKHANN G, DRACHMAN D, FOLSTEIN M, KATZMAN R, PRICE D, STADLAN EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984; 34:939-44.
ROMAN GC, TATEMICHI TK, ERKINJUNTTI T, CUMMING JL, MASDEU JC, GARCÍA JH, ET AL. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993; 43:250-60.
Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry. 1994; 57:416-8.
MCKEITH IG, GALASKO D, KOSAKA K, PERRY EK, DICKSON DW, HANSEN LA, ET AL.Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113-24.
PETERSEN RC, Mild cognitive impairment as a diagnostic entity. Journal of internal medicine. 2004; 256:183-94.
REISBERG B, FERRIS SH, DE LEON MJ, CROOK T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139:1136-9.
CACHO J, BENITO-LEON J, GARCÍA-GARCÍA R, FERNANDEZ-CALVO B, VICENTE-VILLARDON JL, MITCHELL AJ. Does the combination of the MMSE and clock drawing test (mini-clock) improve the detection of mild Alzheimer’s disease and mild cognitive impairment? Journal of Alzheimer’s disease: JAD. 2010; 22:889-96.
POZUETA A, RODRÍGUEZ-RODRÍGUEZ E, VASQUEZ-HIGUERA JL, MATEO I, SANCHEZ-JUAN P, GONZALEZ-PEREZ S, ET AL. Detection of early Alzheimer’s disease in MCI patients by the combination of MMSE and an episodic memory test. BMC neurology. 2011;11:78.
WHITING PF, RUTJES AW, WESTWOOD ME, MALLETT S, DEEKS JJ, REITSMA JB, ET AL. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of internal medicine. 2011;155:529-36.
LOZANO M, HERNÁNDEZ M, TURRO O, PERICOT I, LÓPEZ-POUSA S, VILALTA J. Validación del Montréal Cognitive Assessment (MoCA):
test de cribado para el deterioro cognitivo leve. Datos preliminares. Alzheimer. Real Invest Demenc. 2009;43:4-
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.